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Background: Ginseng, the root of Panax ginseng (PG), is used widely as a herbal medicine to prevent and
treat various diseases. Panax ginseng has pharmacological effects on neurodegenerative diseases such as
Alzheimer’s disease (AD). The present study evaluated the neuroprotective effects of PG and its possible
neuroprotective mechanisms in advanced glycation end product (AGE)-induced AD in a rat model.
Methods: Advanced glycation end products were injected bilaterally into the CA3 region of the rats’
brains. The Morris water maze test and step-down type passive avoidance test were performed to
evaluate their memory and cognitive abilities. The oxidation indexes in the hippocampus were detected.
Immunohistochemistry was conducted to visualize the receptors for advanced glycation end products
(RAGEs) and nuclear factor-kappa-light-chain-enhancer of activated B cell (NF-kB).
Results: Behavioral results showed that PG (1 g/kg, 0.5 g/kg, and 0.25 g/kg) signiﬁcantly shortened the
escape latency, remarkably increased the number of crossing times, signiﬁcantly decreased the number
of errors, and prolonged the latency in rats with AGE-induced AD. Panax ginseng also signiﬁcantly
reduced the malondialdehyde level, increased the glutathione content, and increased superoxide dis-
mutase activity in the hippocampus. Panax ginseng signiﬁcantly decreased the expression of RAGE and
NF-kB. The blockade of anti-RAGE antibody could signiﬁcantly reduce AGE-induced impairments and
regulate these expressions.
Conclusion: Our results demonstrated that PG signiﬁcantly inhibits AGE-induced memory impairment
and attenuates Alzheimer-like pathophysiological changes. These neuroprotective effects of PG may be
associated with the RAGE/NF-kB pathway. Our results provided the experimental basis for applying PG in
preventing and treating AD.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Alzheimer’s disease (AD) is a severe neurodegenerative disorder
of the central nervous system characterized by senile plaque
deposition, neuroﬁbrillary tangle formation, memory loss, and
cognitive impairment. The pathogenesis of AD is not fullyy Systems of Chinese Materia Me
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importance of amyloid-b (Ab) in the progression of the disease [1].
Recent research indicates that advanced glycation end products
(AGEs) derived from the Maillard reaction of glucose and proteins
and lipids can activate receptors for AGEs (RAGE) and lead to the
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X. Tan et al / Ginseng is beneﬁcial for AGE-induced AD 117are colocalized in amyloid plaques in the brains of AD patients
[3e5]. Many experimental studies indicate that the interaction
between AGEs and RAGE elicits intracellular oxidative stress,
proinﬂammatory apoptosis, and oxidative stress responses, which
lead to nerve cell damage [6,7]. These signal transduction pathways
may be associated with RAGE/nuclear factor kappa-light-chain-
enhancer of activated B cell (NF-kB) pathway [8]. These studies
suggest that the AGE/RAGE/NF-kB signaling pathway has important
roles in the lesions or progression of AD [9].
Ginseng, the root of Panax ginseng (PG), has been traditionally
used as a herbal medicine in Asia for at least 2000 yearsdpartic-
ularly in China, Korea, and Japan. Many studies show that PG has
a beneﬁcial effect on the cognitive performance of AD patients
[10e14]. The compounds of PG can prevent Ab formation and
thereby improve spatial memory impairment in rats [15]. Panax
ginseng also attenuates AGE-induced nerve cell damage through
reducing AGEs formation [16]. However, the underlyingmechanism
of PG extract on the beneﬁcial effects of AD remains largely
unknown.
The goals of the present study are: (1) to fully assess the effects
of PG on learning/memory capacity in AGE-induced AD in rats and
(2) to elucidate the underlying mechanism of the neuroprotective
effect of PG on AGE-induced nerve damage. Our ﬁndings in this
study may provide a new insight for understanding the therapeutic
effect of PG on the development of AD.
2. Materials and methods
2.1. Reagents
Bovine serum albumin (BSA), D-glucose and donepezil were
obtained from Sigma-Aldrich (St. Louis, MO, USA). Superoxide
dismutase (SOD), malondialdehyde (MDA), and glutathione (GSH)
kits were ordered from Nanjing Jiancheng Bio Co., Ltd. (Nanjing,
China). Rat NF-kappa B p65 IgG, anti-RAGE antibody (anti-RAGE)
and RAGE antibody were purchased from Santa Cruz Biotechnology
Inc. (Santa Cruz, CA, USA). The AGEs enzyme-linked immunosor-
bent assay (ELISA) kit was obtained from Shanghai Kaibo
Biochemical Reagents Ltd. (Shanghai, China). The other reagents
were of analytically pure grade.
2.2. Preparation of PG extract
The roots of Panax ginseng were purchased from Jiangsu Medi-
cine Company (Nangjing, China) and authenticated by Professor
Min-Jian Qin (Department of Medicinal Plants of the China Phar-
maceutical University, Nanjing, China). The voucher specimens
were deposited in the Key Laboratory of Delivery Systems of Chi-
nese Materia Medica at the Jiangsu Provincial Academy of Chinese
Medicine (Jiangsu, China). The dried medicinal materials of 1000 g
were cut into slices and extracted by reﬂux extraction in 20 L
distilled water twice (2 h each time). After ﬁltration and concen-
tration with a rotary evaporator, the PG extract was obtained (the
yield of PG was 10.4%).
2.3. High-performance liquid chromatography analysis of PG
compounds
The Agilent 1260 high-performance liquid chromatography
(HPLC) system (Agilent Technologies, Palo Alto, MA, USA) was used
for the analysis of compounds of the PG extract. It was equipped
with a quaternary pump, online vacuum degassing pump, auto-
sampler, column oven, diode array detector, and Agilent chem-
station software. The separation columnwas the Prevail C18 column
(i.d., 5 mm; 4.6 mm  250 mm) (RYSS, Shanghai, China). The mobilephase contained water (solvent A) and acetonitrile (solvent B) with
a linear gradient elution program: 0e25 min, 2e23% B; 25e35min,
23e29% B; 35e55 min, 29e40% B; 55e65 min, 40e40% B. The
column temperature was 30C and the injection volume was 10 mL.
The ﬂow rate was maintained at 0.8 mL/min.
2.4. Animals
Adult male Sprague-Dawley rats (280e300 g) were obtained
from the Experimental Animal Center in Jiangsu Province (Nanjing,
China) and housed for 7 d to adapt them to the environment; they
were maintained in a temperature-controlled room (25C  2C)
and maintained on a 12-h/12-h light/dark cycle with food and
water available ad libitum. All experiments and animal care were
performed strictly in accordance with the Provision and General
Recommendation of Chinese Experimental Animals Administration
Legislation and were approved by the Science and Technology
Department of Jiangsu Province.
2.5. Preparation of AGEs
The preparation of AGE proteins (i.e., AGEs-BSA) was performed
as described previously [7]. Bovine serum albumin (5 g) was
incubated with and without D-glucose (9 g) in 0.2M phosphate
buffer saline (PBS; pH, 7.2). After being ﬁltrated through a 0.22-mm
microporous ﬁlm, themixturewasmaintained at 37C for 3months
under sterile conditions. Unincorporated glucose was then
removed by dialysis through a semipermeable membrane against
PBS for 48 h. The prepared AGEs were sterilized by ﬁltration and
maintained at 20C. Advanced glycation end product-speciﬁc
ﬂuorescence was measured at excitation/emission of 370 nm/
440 nm using a ﬂuorescence spectrophotometer (PerkinElmer,
Waltham, MA, USA) and the content was detected by an AGEs ELISA
kit (ﬁnal concentration, 862 mg/mL).
2.6. Drugs and treatment
Rats were anesthetized by an intraperitoneal injection of chloral
hydrate (320 mg/kg) and placed into a stereotaxic device. Two
holes were created for injection at the following
coordinates: 3.4 mm posterior to the bregma, 2.5 mm lateral to
midline, and 3.0 mm dorsal to the ventral dura [17]. Rats were
randomly divided into eight groups (with 10 rats per group), as
follows: (1) normal; (2) BSA; (3) AGEs; (4) AGEsþanti-RAGE; (5)
AGEsþdonepezil; (6) AGEsþPG (1.0); (7) AGEsþPG (0.5); and (8)
AGESþPG (0.25 g/kg). Bovine serum albumin (500 mg) or AGEs
(500 mg) or AGEs (500 mg)þanti-RAGE antibody (50 mg) was injec-
ted bilaterally into the CA3 region of the brains [18]. The rats were
then maintained in a temperature-controlled chamber until they
recovered from anesthesia. Penicillin-G 200,000 IU/mL was intra-
muscularly administered for 3 d to prevent infection [19]. One day
after the operation, the rats in the normal group, BSA group, and
AGEs group received saline water. Donepezil hydrochloride (2 mg/
kg) by oral administration was used for the positive control [19].
The rats in the AGEsþPG groups received PG dissolved in saline
water at dose of 1 g/kg, 0.5 g/kg, or 0.25 g/kg. All drugs were
administered orally for 30 consecutive d.
2.7. Morris water maze test
After drug administration for 25 d, the spatial memory ability of
rats was determined by the Morris water maze test [18]. The test
was performed in a black circular pool (180 cm in diameter and
60 cm in height) with a featureless inner surface. A round platform
was placed 1 cm below the water surface in the center of the target
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consecutively with an intertrial interval of 5 h. Their escape la-
tencies were recorded. Once the rat located the platform, it was
allowed to remain on it for 10 s. If the rat did not locate the platform
within 120 s, it was placed on the platform for 15 s and the escape
latency was recorded as 120 s. After the 5-d training, the platform
was removed for the probe test and each rat was allowed to swim
freely for 120 s. The number of times of crossing the platform was
measured and the swimming trajectory was recorded.
2.8. Step-down type passive avoidance test
The step-down type passive avoidance test was performed in
accordancewith a previously describedmethod of theMorris water
maze test [20]. Rats were placed in the box to adapt for 3 min.
When electric currents (0.5 mA for 2 s) were delivered, the rats
would jump onto the platform to avoid the electric shock. Once the
rats stepped down from the platform, they would be subjected to
an electric shock again, and the electric currents were maintained
for 3min. After a 24-h interval, the rats were placed on the platform
again, and the latency to step down on the grid with two paws
for the ﬁrst time was recorded. The number of errors that were
subjected to shock within 3 min was measured as learning
performance.
2.9. Assays for SOD activity and the content of MDA and GSH
Six rats in each group were sacriﬁced after the behavioral tests.
Their brains were removed and the hippocampi were immediately
dissected on a cold plate, weighed and quickly homogenized with
0.9% ice-cold saline water. The homogenate was centrifuged at
1000  g for 10 min at 4C and the supernatants were collected for
the measurement of SOD activity and levels of MDA and GSH in
accordance with the manufacturer’s instruction.
2.10. Immunohistochemistry for RAGE and NF-kB expressions
The remaining rats from each group were anesthetized with
chloral hydrate (320 mg/kg, i.p.) and sacriﬁced by a transcardial
perfusion of 0.1M PBS (pH, 7.4), followed by 4% paraformaldehyde.
After ﬁxation for 24 h, the brains were dehydrated by serial
gradient concentrations of alcohol, and then embedded in parafﬁn
blocks. Immunohistochemistry was performed on the parafﬁn-
embedded tissue sections (4 mm each piece), as previously
described [21]. After quenching endogenous peroxidase and
blocking with normal goat serum, the sections were incubated
overnight at 4C with rabbit anti-rat antibodies speciﬁc against
RAGE and NF-kB p65, respectively. After washing with PBS, the
sections were incubated at 37C for 2 h with the secondary anti-
bodies, and then stained by 3,30-diaminobenzidine in chromogen
solution. The staining of RAGE and NF-kB was measured by Image
Pro Plus software (IPP 6.0, Media Cybernetics, Rock ville, MD, USA).
Brown staining on the cell membrane or in the cytoplasm repre-
sented positive staining, and the staining density indicated the
expression levels of RAGE and NF-kB.
2.11. Statistical analysis
All values were expressed as the means  the standard devia-
tion and analyzed by one-way analysis of variance (ANOVA), fol-
lowed by Duncan’s multiple range test using SPSS version 13.0
software (SPSS Inc., Chicago, IL, USA). A p value < 0.05 was
considered signiﬁcant and p < 0.01 was considered statistically
very signiﬁcant.3. Results
3.1. The major compounds of PG extract
A HPLC systemwas used to determine the major compounds of
PG extract. As Fig. 1A, B show, the PG extract contains primarily
ginsenosides Rg1, Rb1, Rh1, Rb2, and Rc, after being compared with
mixed standard substances. The retention times of the ﬁve ginse-
nosides were 35.74 min (Rg1), 49.61 min (Rb1), 51.38 min (Rh1),
52.47 min (Rb2), and 53.12 min (Rc). The contents of Rg1, Rb1, Rh1,
Rb2, and Rc were 1.24%, 1.18%, 0.41%, 0.37%, and 0.11%, respectively.
This analysis could provide detailed information on ingredients in
PG samples.3.2. PG increases the learning and memory ability of AD rats
undergoing the Morris water maze test
The Morris water maze test was used to assess the spatial
learning and memory ability of the rats. As Fig. 2A shows, the
mean latency to ﬁnd the platform declined progressively during
the 4 d of training. There was no signiﬁcant statistical difference
between the normal and BSA groups. The rats treated with 500 mg
AGEs spent remarkably more time on ﬁnding the platform,
compared to the control rats (Days 1e4, p < 0.01). These results
revealed that AGEs-treated rats had obvious cognitive impair-
ment. What is more important is that the increase in the escape
latency was shortened by treatment with PG (1 g/kg, 0.5 g/kg, and
0.25 g/kg) from the 2nd d to the 4th d (p< 0.01 and p< 0.05, vs. the
model). The positive controldthe cholinesterase inhibitor done-
pezil (2 mg/kg)dimproved cognitive performance from the 3rd
d to the 4th d (p < 0.01, vs. the model). The anti-RAGE (50 mg)
antibody signiﬁcantly shortened the escape latency from the 2nd
d to 4th d (p < 0.01 and p < 0.05, vs. the model). Fig. 2B illustrates
the swim paths of rats in the second trial on the 2nd d and the 4th
d. Rats tended to explore all four quadrants of the pool on the 2nd
d. On the 4th d, the control rats swam in the direction of the
platform, whereas the AGEs-treated rats took longer swimming
paths. In the probe test, as shown in Fig. 2B, the control rats had
more crossing times (Normal group 6.1  2.0 and BSA group
5.3  1.6, respectively), compared to the AGEs-treated rats
(1.3  1.0, p < 0.01). In addition, the rats treated with PG (1 g/kg,
0.5 g/kg, and 0.25 g/kg) and anti-RAGE antibody had more
crossing times (p < 0.05 and p < 0.01, vs. the model group).
We also measured the time spent in the target quadrant.
However, no signiﬁcant improvement was observed (data not
shown). These results suggested that PG could improve the
learning and memory ability in AGE-induced AD in the rat
models.3.3. Step-down type passive avoidance test
The step-down type passive avoidance test was used to evaluate
the effect of PG on memory ability. Compared to the normal and
BSA rats, AGEs-treated rats exhibited poor performances: the
number of errors signiﬁcantly increased while latency was short-
ened (p < 0.01; Fig. 3A, B). At the doses of 1 g/kg and 0.5 g/kg, PG
treatment signiﬁcantly decreased the number of errors (p < 0.01 or
p < 0.05) and prolonged the latency (p < 0.05 or p < 0.01, vs. the
model group). Treatment with donepezil and the blockage of anti-
RAGE displayed a similar effect (p< 0.05 and p< 0.01, vs. the AGEs-
treated rats). These results suggested that PG could improve the
cognitive function of AGE-induced AD in the rat models in a dose-
dependent manner. Furthermore, this activity may be associated
with the blockade of RAGE.
0 10 2  0 30 40 5 0 60
0 10 2 0 30 40 5 0 60 min
min
1. Rg1 (C42H72O14 , MW=801.01) 2. Rb1 ( C54H92O23 , MW=1109.26)
 3. Rh1 (C36H62O9 , MW=638.87)              4. Rb2 ( C53H90O22, MW= 1079.27)  
A
B
5. Rc (C53H90O22, MW= 1079.27) 
Fig. 1. (A) The HPLC analysis for the following compounds in the PG sample and in the mixed standards: Rg1 (1), Rb1 (2), Rh1 (3), Rb2 (4), and Rc (5). (B) The chemical structures of
the ginsenosides. HPLC, high-performance liquid chromatography; PG. Panax ginseng.
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Fig. 2. The spatial learning and memory ability of rats, based on the Morris water maze test. (A) The latencies to ﬁnd a hidden platform in the water maze during the four
consecutive days of training. (B) Representative search strategy trails of the rats on the 2nd d and the 4th d. The traces show the swim path of all groups of rats. (C) The time in the
target quadrant and number of crossing times on the target platform within 120 s. The data are expressed as the means  the standard deviation (n ¼ 10). #p < 0.05, versus the
normal or BSA group. ##p < 0.01, versus normal or BSA group. *p < 0.05, versus the AGEs model. **p < 0.01, versus the AGEs model. AGE, advanced glycation end product; BSA,
bovine serum albumin; PG, Panax ginseng; RAGE, receptor for advanced glycation end product.
J Ginseng Res 2015;39:116e1241203.4. Effects of PG on SOD activity and levels of MDA and GSH in the
hippocampus
Superoxide dismutase activity, MDA level, and GSH content
were measured to evaluate the attenuation effect of PG on AGE-
induced oxidative damage (Table 1). According to the free radical
theory of aging, the accumulation of reactive oxygen species that
are generated from biological oxidations of normal metabolism
causes oxidative damage and leads to cellular dysfunction [22].
Superoxide dismutase is regarded as the ﬁrst line in the antioxidant
defense system. In the present study, SOD activity was remarkably
inhibited by intracerebral injection of AGEs (p < 0.01). The oral
administration of PG showed a signiﬁcant increase in SOD activity
(p < 0.01 and p < 0.05, vs. the model group), and the positive drugdonepezil and anti-RAGE antibody had a similar protective effect
(p < 0.01 and p < 0.05).
Malondialdehyde is a product of lipid peroxidation from
oxidative damage. Therefore, an elevated level of MDA is associated
with the degree of neuronal degeneration. In this study, the MDA
content in AGEs group was signiﬁcantly increased, compared to the
control groups (p < 0.01). However, this increase was signiﬁcantly
reversed by PG (1 g/kg, 0.5 g/kg, and 0.25 g/kg), anti-RAGE anti-
body, and donepezil.
Glutathione, an endogenous antioxidant against free radicals,
was decreased signiﬁcantly in the hippocampus of AGEs-treated
mice (p < 0.01, vs. the controls). This decrease was interestingly
reversed by PG treatment (p < 0.01 and p < 0.05, vs. the model).
This phenomenon also occurred in the anti-RAGE antibody and
Fig. 3. The step-down type passive avoidance test of rats with AGE-induced cognitive impairment. (A) The average number of errors within 3 min. (B) The average step-down
latency. The data are expressed as the means  the standard deviation (n ¼ 10). ##p < 0.01, versus the normal or BSA group. *p < 0.05, versus the AGEs model. **p < 0.01, versus the
AGEs model. AGE, advanced glycation end product; BSA, bovine serum albumin; PG, Panax ginseng; RAGE, receptor for advanced glycation end product.
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we believed that the reduction of AGE-induced oxidative damage
by PG contributed to its beneﬁcial effect. This function may be
associated with the blockade of the RAGE target.3.5. The effect of PG on the expressions of RAGE and NF-kB in the
cortex and hippocampus
Studies have shown that RAGE is markedly expressed in neu-
rons,microglia, and astrocytes in AD brains. The expression of RAGE
is positively correlated with the severity of AD pathology [23]. The
protein complex NF-kB is activated and involved in regulatingmany
aspects of cellular activity and stress under physiological and
pathological conditions [24]. In our present experiment, the ex-
pressions of RAGE and NF-kB in the cortex and hippocampus of the
rats were analyzed by immunohistochemistry. In the cortex and
hippocampus of rats with AGE-induced AD, the mean densities of
brown staining of RAGE and NF-kB were signiﬁcantly increased
(Figs. 4C, 5C, respectively). However, PG and anti-RAGE antibody
signiﬁcantly downregulated the mean densities of RAGE and NF-kB
in a dose-dependent manner (p < 0.01 and p < 0.05, vs. the AD
model group). These data indicated that PG may attenuate AGE-Table 1
The effects of Panax ginseng on superoxide dismutase activity and the levels of
malondialdehyde and glutathione in the hippocampus of rats treated with advanced
glycation end products
Groups SOD
(U/mg protein)
MDA
(nmol/mg protein)
GSH
(mg/mg protein)
Normal 44.90  2.99 11.30  0.70 29.43  3.50
BSA1) 44.08  2.72 11.55  1.08 28.88  3.34
AGEs2) 35.18  3.02*** 15.85  0.79*** 16.86  2.52***
AGEsþanti-RAGE3) 40.42  3.50* 13.73  0.93* 24.47  3.32*
AGEsþdonepezil4) 39.73  2.64* 14.32  1.07* 27.48  4.07**
AGEsþPG5) 42.23  3.99* 13.38  1.17* 27.52  4.60**
AGEsþPG6) 40.55  3.51* 12.40  0.66* 25.40  3.57**
AGEsþPG7) 38.27  2.26 14.43  1.01 21.33  2.61
All values are expressed as the means  the standard deviation (n ¼ 6).
*p < 0.01, versus AGEs group.
**p < 0.05, versus AGEs group.
***p < 0.01, versus normal or BSA group.
AGE, advanced glycation end product; BSA, bovine serum albumin; GSH, gluta-
thione; MDA, malondialdehyde; PG, Panax ginseng; RAGE, receptor for advanced
glycation end product; SOD, superoxide dismutase.
1) BSA: blank control (500 mg).
2) AGEs: model (500 mg).
3) AGEsþanti-RAGE: positive control [AGEs (500 mg); anti-RAGE (50 mg)].
4) AGEsþdonepezil: positive control [AGEs (500 mg); donepezil (50 mg)].
5) AGEsþPG: AGEs (500 mg); PG (1.0 g/kg).
6) AGEsþPG: AGEs (500 mg); PG (0.5 g/kg).
7) AGEsþPG: AGEs (500 mg); PG (0.25 g/kg).induced cognitive impairment via modulating the RAGE/NF-kB
pathway.
4. Discussion
In this study, the Morris water maze test and step-down type
passive avoidance test were conducted to explore the learning
performances and spatial memory ability of the experimental an-
imals. Immunohistochemistry was used to measure the RAGE and
NF-kB expressions in the cortex and hippocampus of the brains,
whereas SOD activity and levels of MDA and GSH in the hippo-
campus were measured to evaluate the attenuation of PG on
AGE-induced oxidative damage in vivo. Our work showed that PG
attenuated AGE-induced Alzheimer-like behaviors in the rats. The
mechanism of this result may be that PG can inhibit RAGE and NF-
kB expressions and reduce the antioxidation effect in hippocampus.
Advanced glycation end products, which are the nonenzymatic
glycation products from reducing the sugar and amino groups of
proteins, lipids, and other molecules, have been implicated as
important contributors in the pathogenesis of AD. The roles of AGEs
and its receptor (i.e., RAGE) in AD have resulted in increased
scientiﬁc focus [2]. The accumulation of AGEs in intracellular
deposits in normal brains and AD brains is age-dependent and
stage-dependent [25,26]. The binding of AGEs to RAGE activates
oxidative stress and other cascades of signaling events, and ﬁnally
activates redox-sensitive transcription factors such as NF-kB [27]. In
our study, the injection of AGEs in the CA3 area of the rat brain
impaired the performance of the rats in the Morris water maze test
and in the step-down passive avoidance test; these ﬁndings were in
accordance with previous ﬁndings [20]. The better cognitive func-
tions of PG indicate that PG has potential beneﬁt for ameliorating
cognitive deﬁcits induced by AGEs.
The RAGE is an immunoglobulin superfamily cell surface
molecule that was originally discovered as an AGEs-binding re-
ceptor. Increasing evidence shows that interaction between AGEs
and their receptors could activate the NF-kB pathway and result in
neurodegeneration [28]. To further conﬁrm the role of RAGE in
AGE-induced nerve damage, a RAGE blocker (i.e., anti-RAGE anti-
body) was used to block AGE-induced pathological damage. The
blockade of anti-RAGE antibody or PG nearly abolished Alzheimer-
like pathophysiological changes induced by AGEs.
Previous reports have demonstrated that PG can improve
cognitive performance of AD patients [10,11]. The consistency of
our ﬁndings with previous research results supports the fact that
PG could attenuate AGE-induced nerve cell damage through
regulating RAGE activation [16]. The attenuation of PG on AGE-
induced Alzheimer-like pathophysiological changes may be asso-
ciated with its blockade on the interaction between AGEs and RAGE
or on the RAGE-mediated signaling pathway.
Fig. 4. Immunohistochemistry analysis for RAGE expression in (A) the cortex and (B) the hippocampus of rats (original magniﬁcation, 200). (C) The mean density of RAGE
determined by Image Pro Plus (IPP 6.0, Media Cybernetics, Rockville, MD, USA). The data are expressed as the mean  the standard deviation (n ¼ 4). Scale bars ¼ 100 mm.
#p< 0.05, versus the normal or BSA group. ##p < 0.01, versus the normal or BSA group. *p< 0.05, versus the AGEs model. **p < 0.01, versus the AGEs model. AGE, advanced glycation
end product; BSA, bovine serum albumin; PG, Panax ginseng; RAGE, receptor for advanced glycation end product.
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the conditions of high concentrations of AGEs, the endogenous
mechanisms for the maintenance of redox homeostasis are over-
whelmed [29]. Recent evidence indicates that oxidative stress
participates in the induction of Ab levels and has a central role in
the cellular mechanisms of stress tolerance [30]. Accumulating
evidence sheds insight that RAGE-mediated oxidative damage is
an important contributor to neurodegeneration in AD [31]. Gin-
senosides may be primarily responsible for the effect of PG on
oxidative stress by reducing hydroxyl radicals and hypochlorous
acid [32]. Our results demonstrated that PG could attenuateAGE-induced oxidative damage through reducing the levels of
MDA (malondialdehyde, MDA) and by increasing the activity of
SOD and the content of GSH. The improvement of PG on AGE-
induced oxidative damage was similar with anti-RAGE antibody.
The attenuation of PG on oxidative damage may be a RAGE-
mediated oxidative stress response in AGE-induced Alzheimer-like
pathophysiological changes.
The molecule NF-kB, which is in the transcription factor protein
family, serves as an important regulator for downstream signaling
pathways that contribute to the Alzheimer-like pathophysiological
changes. Oxidative stress could activate the NF-kB signaling
Fig. 5. Immunohistochemistry analysis for NF-kB expression in (A) the cortex and (B) the hippocampus of rats (original magniﬁcation, 200). (C) The mean density of NF-kB
determined by Image Pro Plus (IPP 6.0, Media Cybernetics, Rockville, MD, USA). The data are expressed as the mean  the standard deviation (n ¼ 4). Scale bars ¼ 100 mm.
#p < 0.05, versus the normal or BSA. ##p < 0.01, versus the normal or BSA. *p < 0.05, versus the AGEs model. **p < 0.01, versus the AGEs model. AGE, advanced glycation end
product; BSA, bovine serum albumin; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; PG, Panax ginseng; RAGE, receptor for advanced glycation end product.
X. Tan et al / Ginseng is beneﬁcial for AGE-induced AD 123pathway. The beneﬁcial effect of PG on AGE-induced oxidative
damage suggested that PG could inhibit AGE-induced brain damage
through downregulating RAGE and thus inhibiting the activation of
NF-kB in the cortex and hippocampus. This reduction indicated that
the beneﬁcial effect of PG on AGE-induced cognitive deﬁcits may be
associated with its regulation of NF-kB activation and oxidative
stress through downregulating RAGE. However, the downstream
signaling pathways need to be further investigated to reveal this
mechanism.In conclusion, our results provide insights into the improvement
of PG on AGE-induced AD-like pathophysiological changes. Panax
ginseng could enhance signiﬁcantly the learning and memory
ability of AD rats and attenuate oxidative stress damage. A possible
mechanism may be associated with its blockade of RAGE/NF-kB
activation. Further studies are required to elucidate the signaling
events of PG that contribute to its protection mechanisms on
AGE-induced AD. Furthermore, more studies need to explore the
primary effective components in PG. Our results provide the
J Ginseng Res 2015;39:116e124124experimental basis for the application of PG in preventive or ther-
apeutic strategies in AD.
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